William Blair Forecasts DENTSPLY SIRONA FY2024 Earnings

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Investment analysts at William Blair dropped their FY2024 EPS estimates for shares of DENTSPLY SIRONA in a report released on Thursday, November 7th. William Blair analyst B. Vazquez now forecasts that the medical instruments supplier will post earnings of $1.84 per share for the year, down from their prior estimate of $1.98. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA’s Q1 2025 earnings at $0.41 EPS, Q2 2025 earnings at $0.52 EPS, Q3 2025 earnings at $0.53 EPS, Q4 2025 earnings at $0.50 EPS, Q2 2026 earnings at $0.58 EPS and Q3 2026 earnings at $0.58 EPS.

Several other equities analysts have also issued reports on XRAY. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Wednesday, November 6th. Needham & Company LLC dropped their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Finally, Stifel Nicolaus dropped their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Stock Performance

XRAY stock opened at $17.65 on Monday. The firm has a market cap of $3.58 billion, a PE ratio of -8.53, a P/E/G ratio of 0.97 and a beta of 1.02. The company has a quick ratio of 0.87, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business has a 50 day moving average of $24.52 and a 200-day moving average of $25.74. DENTSPLY SIRONA has a 12-month low of $17.21 and a 12-month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.49 earnings per share.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently made changes to their positions in the business. UMB Bank n.a. increased its stake in DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after acquiring an additional 753 shares during the last quarter. Capital Performance Advisors LLP bought a new position in DENTSPLY SIRONA in the third quarter valued at $27,000. LRI Investments LLC grew its stake in shares of DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the last quarter. Kennebec Savings Bank bought a new position in shares of DENTSPLY SIRONA during the third quarter valued at about $35,000. Finally, Rothschild Investment LLC bought a new position in shares of DENTSPLY SIRONA during the second quarter valued at about $32,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.